Home Articles List Article Information
Iranian Journal of Pathology
Journal Archive
Volume Volume 14 (2019)
Volume Volume 13 (2018)
Volume Volume 12 (2017)
Volume Volume 11 (2016)
Volume Volume 10 (2015)
Volume Volume 9 (2014)
Volume Volume 8 (2013)
Volume Volume 7 (2012)
Volume Volume 6 (2011)
Volume Volume 5 (2010)
Volume Volume 4 (2009)
Volume Volume 3 (2008)
Volume Volume 2 (2007)
Volume Volume 1 (2006)
Yaghobi, A., Azadeh, P., . Moghadam, S., Shafaghi, B. (2010). Primary Stromal Sarcoma of Breast with Nodal Recurrence. Iranian Journal of Pathology, 5(1), 43-46.
Ali Yaghobi; Payam Azadeh; Sh . Moghadam; Behrouz Shafaghi. "Primary Stromal Sarcoma of Breast with Nodal Recurrence". Iranian Journal of Pathology, 5, 1, 2010, 43-46.
Yaghobi, A., Azadeh, P., . Moghadam, S., Shafaghi, B. (2010). 'Primary Stromal Sarcoma of Breast with Nodal Recurrence', Iranian Journal of Pathology, 5(1), pp. 43-46.
Yaghobi, A., Azadeh, P., . Moghadam, S., Shafaghi, B. Primary Stromal Sarcoma of Breast with Nodal Recurrence. Iranian Journal of Pathology, 2010; 5(1): 43-46.

Primary Stromal Sarcoma of Breast with Nodal Recurrence

Article 10, Volume 5, Issue 1, Winter 2010, Page 43-46  XML PDF (1.32 MB)
Document Type: Case Reports
Authors
Ali Yaghobi email 1; Payam Azadeh2; Sh . Moghadam3; Behrouz Shafaghi4
1Dept. of Radiotherapic oncology, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2. Dept of Radiotherapic oncology, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3Dept of Radiotherapic oncology, Shahid Beheshti University of Medical Sciences, Tehran, Iran
4Dept. of Pathology, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Abstract
  Although most breast cancers are adenocarcinomas of the mammary gland, primary breast sarcomas may also arise from mammary gland mesenchymal tissue. Sarcomas represent less than 1% of primary breast neoplasms. These tumors are at high risk of recurrence and are known to have poor prognosis. Surgical resection is the primary treatment for these lesions and axillary lymph node dissection is not routinely indicated in the setting of a clinically negative axilla. In this report, we introduce a patient with breast stromal sarcoma based on surgical pathology that has experienced axillary lymph node recurrence later during follow up period.    
Keywords
Breast; Sarcoma; Adenocarcinoma; Iran
Statistics
Article View: 1,530
PDF Download: 1,028